Founder & CEO
Profile summary: MS in Physics/Aeronautics Composites Core Program at Stanford University
Mitrix.bio
4/10Traction
The startup specializes in mitochondrial transfusion therapy to combat age-related diseases such as Alzheimer's and Parkinson's. By enhancing mitochondrial function, the company aims to improve healing processes and reduce frailty in elderly patients and wounded soldiers.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$780KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 known round
$250K · Pre-Seed
Announced Jan 2021
Disclosed cumulative: $250K
Reported total $780K
Incomplete round history. $530K of the $780K reported total isn’t matched to a known round.
RoundDateAmountValuationInvestors
Founders
Product
Features
- The startup specializes in mitochondrial transfusion therapy to combat age-related diseases such as Alzheimer's and Parkinson's. By enhancing mitochondrial function, the company aims to improve healing processes and reduce frailty in elderly patients and wounded soldiers.